Cours MYnd Analytics Inc Nasdaq
Actions
US62857N2027
Recherche biotechnologique et médicale
CA 2021 | 20,61 M 18,86 M | CA 2022 | 18,39 M 16,83 M | Capitalisation | 12,9 M 11,8 M |
---|---|---|---|---|---|
Résultat net 2021 | -15 M -13,73 M | Résultat net 2022 | -10 M -9,15 M | VE / CA 2021 | 4,97 x |
Dette nette 2021 | 20,13 M 18,42 M | Dette nette 2022 | 28,8 M 26,35 M | VE / CA 2022 | 2,27 x |
PER 2021 |
-5,16
x | PER 2022 |
-1,21
x | Employés | - |
Rendement 2021 * |
-
| Rendement 2022 |
-
| Flottant | 48,23% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
George Sekulich
PSD | President | 59 | 01/05/19 |
Willis Lee
CHM | Chairman | 64 | 17/07/19 |
Yasushi Nagasaki
DFI | Director of Finance/CFO | 57 | 01/05/11 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Wei Peu Zen
BRD | Director/Board Member | 71 | 17/07/19 |
Willis Lee
CHM | Chairman | 64 | 17/07/19 |
Ian Zwicker
BRD | Director/Board Member | 77 | 17/07/19 |
Varia. 1 janv. | Capi. | |
---|---|---|
+64,23% | 55,07 Md | |
-2,31% | 41,79 Md | |
+44,36% | 40,22 Md | |
-8,29% | 28,17 Md | |
+11,97% | 26,28 Md | |
-21,16% | 18,93 Md | |
+7,54% | 13,03 Md | |
+27,17% | 12,26 Md | |
+25,72% | 12,21 Md |